HDAC8 and neuroblastoma: Among them, St.28 (Table 4) underscored strong antiproliferative activity against neuroblastoma cell lines and showed significant in vivo efficacy in a BE(2)-C xenograft mouse model, highlighting its promise as a new HDAC8-targeted anticancer agent [134].